Is This Science or Censorship? Statin guidelines, heart disease, and threats to evidence-based publishing

There are two parts to this story. The first involves a scientific debate about new guidelines for prescribing cholesterol-lowering drugs. The second is about threats to that scientific debate, as an industry heavyweight in support of the guidelines holds court in mass media to demand retraction of two research articles (published in the international medical . . . → Read More: Is This Science or Censorship?